All In MedTech

FDA Clearance Tracker · P030052-S001

UROVYSION BLADDER CANCER KIT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 10, 2006 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 10, 2006

Approved

Time to decision

324 days

Received Jun 20, 2005. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030052-S001
Device name
UROVYSION BLADDER CANCER KIT
Applicant location
Des Plaines, IL
Received
Jun 20, 2005
Decided
May 10, 2006
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Express GMP Supplement
Original approval
P030052

Device type

Device class
Class III

Every decision under product code NSD

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT ABBOTT DES PLAINES, DES PLAINES, ILLINOIS.

Source documents

Other decisions for Abbott Molecular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.